Cargando…

Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective

BACKGROUND: In Australia, the reimbursement of botulinum neurotoxin-A (BoNT-A) on the Pharmaceutical Benefits Scheme for the treatment of moderate to severe spasticity of the upper limb following a stroke (PSS-UL) is restricted to four treatment cycles per upper limb per lifetime. This analysis exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makino, Koji, Tilden, Dominic, Guarnieri, Carmel, Mudge, Mia, Baguley, Ian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393278/ https://www.ncbi.nlm.nih.gov/pubmed/29915932 http://dx.doi.org/10.1007/s41669-018-0086-z

Ejemplares similares

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
por: Makino, Koji, et al.
Publicado: (2020)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020)

Cost‐effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia
por: Thijs, Vincent, et al.
Publicado: (2021)

Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis
por: Kaňovský, Petr, et al.
Publicado: (2021)

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

IncobotulinumtoxinA for Post-stroke Upper Limb Spasticity in Neutralizing Antibody-positive Patients after Botulinum Toxin Therapy: A Report of Two Cases
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania
por: Turcu-Stiolica, Adina, et al.
Publicado: (2020)

Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy
por: Kaňovský, Petr, et al.
Publicado: (2022)

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
por: Marciniak, Christina, et al.
Publicado: (2018)

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Wissel, Jörg, et al.
Publicado: (2021)

Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
por: Masakado, Yoshihisa, et al.
Publicado: (2020)

The role of neurectomy in the management of spasticity of the upper limb
por: Mikalef, Petros, et al.
Publicado: (2017)

Balneotherapy in Treatment of Spastic Upper Limb after Stroke
por: Erceg-Rukavina, Tatjana, et al.
Publicado: (2015)

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
por: Santamato, Andrea
Publicado: (2016)

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study(1)
por: Heinen, Florian, et al.
Publicado: (2021)

Effect of post-stroke spasticity on voluntary movement of the upper limb
por: Lackritz, Hadar, et al.
Publicado: (2021)

Difficult conditions of the spastic upper limb
por: Bhardwaj, Praveen
Publicado: (2015)

Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial
por: Shackley, Phil, et al.
Publicado: (2012)

Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013)

Randomized, placebo‐controlled trial of incobotulinumtoxina for upper‐limb post‐stroke spasticity
por: Elovic, Elie Paul, et al.
Publicado: (2015)

Post-stroke Upper Limb Spasticity Incidence for Different Cerebral Infarction Site
por: Jin, Yi, et al.
Publicado: (2018)

Effective Management of Upper Limb Parkinsonian Tremor by IncobotulinumtoxinA Injections Using Sensor-based Biomechanical Patterns
por: Rahimi, Fariborz, et al.
Publicado: (2015)

“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
por: Ianieri, Giancarlo, et al.
Publicado: (2018)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
por: Berweck, Steffen, et al.
Publicado: (2022)

Association between Severe Upper Limb Spasticity and Brain Lesion Location in Stroke Patients
por: Picelli, Alessandro, et al.
Publicado: (2014)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020)

Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke
por: Duan, Haoyang, et al.
Publicado: (2023)

Upper limb impairments associated with spasticity in neurological disorders
por: Tsao, Cheng-Chi, et al.
Publicado: (2007)

Early prediction of long-term upper limb spasticity after stroke: Part of the SALGOT study
por: Opheim, Arve, et al.
Publicado: (2015)

Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
por: Veverka, Tomáš, et al.
Publicado: (2019)

Effect of Tui Na on upper limb spasticity after stroke: a randomized clinical trial
por: Wang, Meng, et al.
Publicado: (2019)

Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia
por: Trompetto, Carlo, et al.
Publicado: (2022)

IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy – a retrospective case series focusing on dosing and tolerability
por: León-Valenzuela, Angel, et al.
Publicado: (2020)

Outcome of selective motor fasciculotomy in the treatment of upper limb spasticity
por: Puligopu, Aneel Kumar, et al.
Publicado: (2011)

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors
por: Pundik, Svetlana, et al.
Publicado: (2014)

Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018)

Spasticity Assessment Based on the Maximum Isometrics Voluntary Contraction of Upper Limb Muscles in Post-stroke Hemiplegia
por: Wang, Hui, et al.
Publicado: (2019)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fbn9i7igeuij653arprogi50lg